ArticlePloS one2024
Deep learning empowered breast cancer diagnosis: Advancements in detection and classification.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- MMBCFNet: multi modal hybrid deep learning framework for breast cancer detection using MRI, mammography, and ultrasound images.Journal of ultrasound · 2026Article
- Machine Learning and Explainable AI for Breast Cancer Patient Prioritization: An Intelligent Decision-Support Framework.Bioengineering (Basel, Switzerland) · 2026Article
- Explainable Breast Cancer Detection Using Hierarchical Multi-Scale and Edge-Aware Transformer Networks.Bioengineering (Basel, Switzerland) · 2026Article
- Transformer based breast cancer classification from histopathological images using sequential residual recurrent multiscale attention network.Scientific reports · 2026Article
- MassSeg-Framework: A Breast Mass Detection and Segmentation Framework Based on Deep Learning and an Active Contour Model.Life (Basel, Switzerland) · 2026Article
- The Burden of Breast Cancer and its Attributable Risk Factors in 204 Countries and Territories, 1990-2021: Results From the Global Burden of Disease Study 2021.Cancer innovation · 2026Article
- Hybrid tuned deep learning model for breast cancer diagnosis using genetic data.Scientific reports · 2026Article
- A multi-scale adaptive filtering and AtRes_SRU-transformer synergy for breast cancer histopathology classification.Scientific reports · 2026Article
- Adding artificial intelligence case malignancy scoring to reduce screen-reading workload in breast screening program: results of the retrospective REAI program.La Radiologia medica · 2026Article
- Article
- A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents.Translational cancer research · 2026Article
- Resilient Sinkhorn-Based Optimal Transport Late Fusion Framework for Breast Cancer Diagnosis.Cancer informatics · 2026Article
- Sequence-robust MRI asymmetry measures for the detection of anoperineal lesions in Crohn's disease on axial pelvic MRI scans.PloS one · 2026Article
- The role of AI for improved management of breast cancer: Enhanced diagnosis and health disparity mitigation.Computer methods and programs in biomedicine · 2025Review
- Research progress in computer-aided diagnosis systems for lung cancer.NPJ digital medicine · 2025Review
- Multimodal fusion of ultrasound images using HXM net for breast cancer diagnosis.Scientific reports · 2025Article
- HyFusion-X: hybrid deep and traditional feature fusion with ensemble classifiers for breast cancer detection using mammogram and ultrasound images.Scientific reports · 2025Article
- Review of Artificial Intelligence Techniques for Breast Cancer Detection with Different Modalities: Mammography, Ultrasound, and Thermography Images.Bioengineering (Basel, Switzerland) · 2025Review
- Research status and progress of deep learning in automatic esophageal cancer detection.World journal of gastrointestinal oncology · 2025Review
- Hybrid convolutional neural network and bi-LSTM model with EfficientNet-B0 for high-accuracy breast cancer detection and classification.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advancements in AI, driven by big data technologies, have reshaped various industries, with a strong focus on data-driven approaches. This has resulted in remarkable progress in fields like computer vision, e-commerce, cybersecurity, and healthcare, primarily fueled by the integration of machine learning and deep learning models. Notably, the intersection of oncology and computer science has given rise to Computer-Aided Diagnosis (CAD) systems, offering vital tools to aid medical professionals in tumor detection, classification, recurrence tracking, and prognosis prediction. Breast cancer, a significant global health concern, is particularly prevalent in Asia due to diverse factors like lifestyle, genetics, environmental exposures, and healthcare accessibility. Early detection through mammography screening is critical, but the accuracy of mammograms can vary due to factors like breast composition and tumor characteristics, leading to potential misdiagnoses. To address this, an innovative CAD system leveraging deep learning and computer vision techniques was introduced. This system enhances breast cancer diagnosis by independently identifying and categorizing breast lesions, segmenting mass lesions, and classifying them based on pathology. Thorough validation using the Curated Breast Imaging Subset of Digital Database for Screening Mammography (CBIS-DDSM) demonstrated the CAD system's exceptional performance, with a 99% success rate in detecting and classifying breast masses. While the accuracy of detection is 98.5%, when segmenting breast masses into separate groups for examination, the method's performance was approximately 95.39%. Upon completing all the analysis, the system's classification phase yielded an overall accuracy of 99.16% for classification. The potential for this integrated framework to outperform current deep learning techniques is proposed, despite potential challenges related to the high number of trainable parameters. Ultimately, this recommended framework offers valuable support to researchers and physicians in breast cancer diagnosis by harnessing cutting-edge AI and image processing technologies, extending recent advances in deep learning to the medical domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.